Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001171843-25-003916 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-16 | 2025-06-12 | BCRX | McKee Amy E | Dir | A - Grant | $0.00 | +12.5K | 40.3K | +45% | $0 |
| D | 2025-06-16 | 2025-06-12 | BCRX | McKee Amy E | Dir | A - Grant | $0.00 | +27.2K | 27.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | A | A | 12,500 | $0.00 | 40,331 | D | — | — | (F1) Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. |
| 2 | Derivative | Automatic Stock Option Grant | 2025-06-12 | A | A | 27,181 | $0.00 | 27,181 | D | $10.40 · 2026-06-12 to 2035-06-12 | 27,181 Common Stock | (F2) Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. |